Targretin (bexarotene 1% gel) — Medica
Primary cutaneous B-cell lymphoma (primary cutaneous marginal zone lymphoma or follicle center lymphoma)
Initial criteria
- Medication is used as skin-directed therapy for one of the following: primary cutaneous marginal zone lymphoma OR follicle center lymphoma
- Medication is prescribed by or in consultation with an oncologist or a dermatologist
Approval duration
1 year